Yaşlanmaya İlişkin Testiküler Bozulmalarda MMP-2 ve VEGF'nin Olası Etkileşimi
Amaç: Yaşlılarda, erektil disfonksiyon ve hipogonadizm, insan yaşamının uzaması nedeniyle daha önemli hale gelmiştir. Vasküler bozukluklar, kronik hipoksi, fibrozis ve hormonal değişiklikler yaşlı testisinde oluşan morfolojik değişikliklere yol açar. Vasküler endotelyal büyüme faktörü (VEGF) ve matriks metalloproteinaz-2 (MMP-2) hem morfolojik değişiklikler ile, hem de sperm hareketliliği ve canlılığı ile doğrudan ilişkilidir. VEGF ve MMP-2'nin yaşlı testisindeki yapısal ve fonksiyonel bozukluklara katkısı iyi bilinmemektedir. Bu çalışmanın amacı yaşlı testisinde VEGF ve MMP-2 düzeylerinin değişimini ve birbirleriyle etkileşimlerini belirlemektir. Yöntemler: Yaşlı sıçanlarda (26-30 ay) ve erişkin sıçanlarda (8-10 ay) testis dokusundaki MMP-2 ve VEGF düzeyleri ELISA yöntemi ile analiz edildi. Serum total testosteron düzeyleri immunoassay yöntemi kullanılarak analiz edildi. İstatistiksel analiz Mann Whitney-U testi kullanılarak yapıldı, p
Probable Interaction of MMP-2 and VEGF in Testicular Deteriorations Related to Aging
Objective: In the elderly, erectile dysfunction and hypogonadism have become more important due to the extension ofhuman life. The most important morphological changes of the aged testis are associated with vascular deterioration,chronic hypoxia, fibrosis and hormonal changes. Vascular Endothelial Growth Factor (VEGF) and MatrixMetalloproteinase-2 (MMP-2) are directly related to these changes along with sperm motility and viability. Thecontribution of VEGF and MMP-2 to the structural and functional disturbances in the aged testis is unknown. The aimof this study was to determine VEGF and MMP-2 levels in the elderly testis and their interactions with one another.Method: The testis tissues of aged rats (26-30 months) and adult rats (8-10 months) were analysed using the ELISAmethod to determine MMP-2 and VEGF levels. Serum total testosterone levels were analyzed using the immunoassaymethod. The statistical analysis was performed using the Mann Whitney-U test, p
___
- 1. Gokce MI, Yaman O. Erectile dysfunction in the elderly
male. Turk J Urol 2017; 43: 247-51.
- 2. Ryu J-K, Suh J-K. Regenerative technology for future
therapy of erectile dysfunction. Transl Androl Urol
2012; 1: 173-80.
- 3. Ergun S, Kilic N, Fiedler W, et al. Vascular endothelial
growth factor and its receptors in normal human
testicular tissue. Mol Cell Endocrinol 1997; 131: 9-20.
- 4. Santiago J, Silva JV, Alves MG, et al. Testicular aging: an
overview of ultrastructural, cellular and molecular
alterations. J Gerontol A Biol Sci Med Sci 2019; 74: 860-
71.
- 5. Regadera J, Nistal M, Paniagua R. Testis, epididymis,
and spermatic cord in elderly men. Correlation of
angiographic and histologic studies with systemic
arteriosclerosis. Arch Pathol Lab Med 1985; 109: 663-
7.
- 6. Guo H, Zhou H, Lu J, et al. Vascular endothelial growth
factor: an attractive target in the treatment of
hypoxic/ischemic brain injury. Neural Regen Res 2016;
11: 174-9.
- 7. Yan-Ping D, Xiao-Qin G, Xiao Ping M, et al. Effects of
Chronic Exposure to Sodium Arsenite on Expressions of
VEGF and VEGFR2 Proteins in the Epididymis of Rats.
Biomed Res Int 2017; 2017: 2597256.
- 8. Tian R, Yang S, Zhu Y, et al. VEGF/VEGFR2 Signaling
Regulates Germ Cell Proliferation in vitro and Promotes
Mouse Testicular Regeneration in vivo. Cells Tissues
Organs 2016; 201: 1-13.
- 9. Mittal R, Patel AP, Debs LH, et al. Intricate Functions of
Matrix Metalloproteinases in Physiological and
Pathological Conditions. J Cell Physiol 2016; 231: 2599-
621.
- 10. Donato Anthony J, Machin Daniel R, Lesniewski Lisa
A. Mechanisms of Dysfunction in the Aging Vasculature
and Role in Age-Related Disease. Circ Res 2018; 123:
825-48.
- 11. Liu Y, Zhang H, Yan L, et al. MMP-2 and MMP-9
contribute to the angiogenic effect produced by
hypoxia/15-HETE in pulmonary endothelial cells. J Mol
Cell Cardiol 2018; 121: 36-50.
- 12. Warinrak C, Wu JT, Hsu WL, et al. Expression of
matrix metalloproteinases (MMP-2, MMP-9) and their
inhibitors (TIMP-1, TIMP-2) in canine testis,
epididymis and semen. Reprod Domest Anim 2015; 50:
48-57.
- 13. Belardin LB, Antoniassi MP, Camargo M, et al. Semen
levels of matrix metalloproteinase (MMP) and tissue
inhibitor of metalloproteinases (TIMP) protein families
members in men with high and low sperm DNA
fragmentation. Sci Rep 2019; 9: 10234.
- 14. Kohler I, Meier R, Busato A, et al. Is carbon dioxide
(CO2) a useful short acting anaesthetic for small
laboratory animals? Lab Anim 1999; 33: 155-61.
- 15. Pop OT, Cotoi CG, Plesea IE, et al. Correlations
between intralobular interstitial morphological
changes and epithelial changes in ageing testis. Rom J
Morphol Embryol 2011; 52: 339-47.
- 16. Lee HC, Tsai SJ. Endocrine targets of hypoxiainducible factors. J Endocrinol 2017; 234: R53-R65.
- 17. Basaria S. Reproductive aging in men. Endocrinol
Metab Clin North Am 2013; 42: 255-70.
- 18. Zhang G, Kang Y, Zhou C, et al. Amelioratory Effects of
Testosterone Propionate on Age-related Renal Fibrosis
via Suppression of TGF-beta1/Smad Signaling and
Activation of Nrf2-ARE Signaling. Sci Rep 2018; 8:
10726.
- 19. Chung CC, Hsu RC, Kao YH, et al. Androgen attenuates
cardiac fibroblasts activations through modulations of
transforming growth factor-beta and angiotensin II
signaling. Int J Cardiol 2014; 176: 386-93.
- 20. Zhang J, Salamonsen LA. Expression of hypoxiainducible factors in human endometrium and
suppression of matrix metalloproteinases under
hypoxic conditions do not support a major role for
hypoxia in regulating tissue breakdown at
menstruation. Hum Reprod 2002; 17: 265-74.
- 21. Belardin LB, Antoniassi MP, Camargo M, et al. Semen
levels of matrix metalloproteinase (MMP) and tissue
inhibitor of metallorproteinases (TIMP) protein
families members in men with high and low sperm
DNA fragmentation. Sci Rep 2019; 9: 903.
- 22. Marneros AG. Effects of chronically increased VEGF-A
on the aging heart. FASEB J 2018; 32: 1550-65.
- 23. Kozhevnikova OS, Fursova AZ, Markovets AM, et al.
VEGF and PEDF levels in the rat retina: effects of aging
and AMD-like retinopathy. Adv Gerontol 2018; 31: 339-
44.
- 24. Barratt SL, Blythe T, Ourradi K, et al. Effects of
hypoxia and hyperoxia on the differential expression of
VEGF-A isoforms and receptors in Idiopathic
Pulmonary Fibrosis (IPF). Respir Res 2018; 19: 9.
- 25. Sounni NE, Roghi C, Chabottaux V, et al. Up-regulation
of vascular endothelial growth factor-A by active
membrane-type 1 matrix metalloproteinase through
activation of Src-tyrosine kinases. J Biol Chem 2004;
279: 13564-13574.
- 26. Ferrara N. Binding to the extracellular matrix and
proteolytic processing: two key mechanisms regulating
vascular endothelial growth factor action. Mol Biol Cell
2010; 21: 687-90.
- 27. Lee S, Jilani SM, Nikolova GV, et al. Processing of
VEGF-A by matrix metalloproteinases regulates
bioavailability and vascular patterning in tumors. J Cell
Biol 2005; 169: 681-91.
- 28. Ebrahem Q, Chaurasia SS, Vasanji A, et al. Cross-talk
between vascular endothelial growth factor and matrix
metalloproteinases in the induction of
neovascularization in vivo. Am J Pathol 2010; 176: 496-
503.
- 29. Lee RJ, Springer ML, Blanco-Bose WE, et al. VEGF
gene delivery to myocardium: deleterious effects of
unregulated expression. Circulation 2000; 102: 898-
901.
- 30. Melincovici CS, Boşca AB, Şuşman S, et al. Vascular
endothelial growth factor (VEGF) - key factor in normal
and pathological angiogenesis. Rom J Morphol Embryol
2018; 59: 455-67.